Voyager Therapeutics, Inc.
US ˙ NasdaqGS ˙ US92915B1061

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Steven M Paul. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Steven M Paul har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Director 477.642
US:KRTX / Karuna Therapeutics, Inc. Director 0
US:SAGE / Sage Therapeutics, Inc. Director 78.539
US:ALNY / Alnylam Pharmaceuticals, Inc. Director 0
US:VYGR / Voyager Therapeutics, Inc. Director 15.000
US:SIAL / Sigma-Aldrich Corporation Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Steven M Paul. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb VYGR / Voyager Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VYGR / Voyager Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2016-01-14 VYGR PAUL STEVEN M 10.000 14,0690 10.000 14,0690 140.690 207 16.2600 21.910 15,57

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VYGR / Voyager Therapeutics, Inc. Insider Trades
Insidersalg VYGR / Voyager Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VYGR / Voyager Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VYGR / Voyager Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Steven M Paul som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-06-06 3 RAPP Rapport Therapeutics, Inc.
Common Stock
477.642
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -35.877 0 -100,00 330,00 -11.839.410
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -30.304 0 -100,00 330,00 -10.000.320
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -30.304 0 -100,00 330,00 -10.000.320
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -33.882 0 -100,00 330,00 -11.181.060
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -10.000 0 -100,00 330,00 -3.300.000
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -8.550 0 -100,00 330,00 -2.821.500
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -2.046 8.550 -19,31 330,00 -675.180 2.821.500
2024-03-04 2024-03-04 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30.304 30.304
2024-03-04 2024-03-04 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30.304 2.364 -92,76
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30.304 32.668 1.281,90
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30.304 32.668 1.281,90
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30.304 10.000 -75,19
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30.304 10.000 -75,19
2024-03-04 2024-02-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
J - Other 47.378 70.608 203,95 315,18 14.932.598 22.254.229
2024-02-26 2024-02-23 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 4.008 42.114 10,52 99,72 399.678 4.199.608
2024-02-26 2024-02-23 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 27.510 38.106 259,63 7,27 199.998 277.031
2024-02-12 2024-02-09 4 KRTX Karuna Therapeutics, Inc.
Common Stock
F - Taxes -804 10.596 -7,05 317,14 -254.981 3.360.415
2023-02-13 2023-02-09 4 KRTX Karuna Therapeutics, Inc.
Common Stock
A - Award 11.400 11.400
2023-02-13 2022-05-31 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 106.485 106.485
2023-02-13 2022-05-31 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -106.485 0 -100,00
2023-02-13 2022-05-27 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 106.485 106.485
2023-02-13 2022-05-27 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -106.485 0 -100,00
2022-11-30 2022-11-28 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 5 78.539 0,01 38,17 191 2.997.637
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -15.000 0 -100,00
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -175 1.000 -14,89 178,60 -31.255 178.600
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -825 1.175 -41,25 177,58 -146.504 208.656
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -526 2.000 -20,82 176,51 -92.844 353.020
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -90 2.526 -3,44 174,33 -15.690 440.358
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -642 2.616 -19,71 173,06 -111.105 452.725
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.434 3.258 -30,56 172,10 -246.791 560.702
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.235 4.692 -20,84 171,16 -211.383 803.083
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.872 5.927 -45,12 169,71 -826.827 1.005.871
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.948 10.799 -31,42 168,95 -835.965 1.824.491
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -253 15.747 -1,58 166,04 -42.008 2.614.632
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.000 16.000 1.500,00 11,33 169.950 181.280
2022-02-17 2022-02-16 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 146.900 146.900
2022-01-05 2022-01-04 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 1.638 1.638
2021-11-12 2021-11-09 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 1 1 43,36 43 43
2021-08-18 2021-08-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 1.181 108.849 1,10 106,10 125.304 11.548.879
2021-08-18 2021-08-17 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 1.183 107.668 1,11 105,63 124.960 11.372.971
2021-07-19 2021-07-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.032 4.032
2021-06-11 2021-06-10 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2021-06-04 2021-06-03 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2021-02-24 2021-02-23 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 161.850 161.850
2021-01-15 2020-03-31 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift 292.207 292.207
2021-01-15 2020-03-31 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift -292.207 0 -100,00
2021-01-15 2020-03-30 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift 292.207 292.207
2021-01-15 2020-03-30 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift -292.207 0 -100,00
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -15.000 0 -100,00
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.000 1.000 -93,75 140,00 -2.100.000 140.000
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.000 16.000 1.500,00 9,30 139.500 148.800
2020-07-06 2020-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.581 4.581
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
M - Exercise -292.207 0 -100,00
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
S - Sale -292.207 106.485 -73,29 103,50 -30.243.424 11.021.198
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 292.207 398.692 274,41 0,11 32.143 43.856
2020-06-11 2020-06-09 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2020-06-05 2020-06-04 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2020-02-19 2020-02-14 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -140.000 140.000 -50,00
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -30.000 0 -100,00
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -30.000 1.000 -96,77 130,00 -3.900.000 130.000
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 30.000 31.000 3.000,00 14,67 440.100 454.770
2019-07-02 2019-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9.000 9.000
2019-07-02 2019-07-02 4 KRTX Karuna Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -74.294 0 -100,00
2019-07-02 2019-07-02 4 KRTX Karuna Therapeutics, Inc.
Common Stock
C - Conversion 96.485 106.485 964,85
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -71.121 71.121 -50,00
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 3.200 10.000 47,06 23,43 74.976 234.300
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 6.800 6.800 22,86 155.448 155.448
2019-07-01 2019-06-27 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -616.703 616.703 -50,00
2019-06-17 2019-06-13 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2019-06-06 2019-06-05 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1.967 122.400 -1,58 161,02 -316.726 19.708.848
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -2.919 124.367 -2,29 161,05 -470.105 20.029.305
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -2.993 127.286 -2,30 161,04 -481.993 20.498.137
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -13.047 130.279 -9,10 161,35 -2.105.133 21.020.517
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -13.096 143.326 -8,37 161,32 -2.112.647 23.121.350
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -16.182 156.422 -9,38 161,20 -2.608.538 25.215.226
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -14.321 172.604 -7,66 161,32 -2.310.264 27.844.477
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -875 186.925 -0,47 161,01 -140.884 30.096.794
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -800 187.800 -0,42 161,02 -128.816 30.239.556
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1.200 188.600 -0,63 161,14 -193.368 30.391.004
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -900 189.800 -0,47 161,01 -144.909 30.559.698
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190.700 -0,37 161,00 -112.700 30.702.700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190.700 -0,37 161,00 -112.700 30.702.700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190.700 -0,37 161,00 -112.700 30.702.700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 192.100 -0,26 161,00 -80.500 30.928.100
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30.600 193.300 18,81
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30.600 193.300 18,81
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30.600 435.477 7,56
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30.600 404.877 8,18
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -122.400 119.295 -50,64
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 70.900 -0,70 161,00 -80.500 11.414.900
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 70.900 -0,70 161,00 -80.500 11.414.900
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 344.177 -0,15 161,00 -80.500 55.412.497
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 344.677 -0,14 161,00 -80.500 55.492.997
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -200 72.900 -0,27 162,00 -32.400 11.809.800
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -200 72.900 -0,27 162,00 -32.400 11.809.800
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -643 73.100 -0,87 161,37 -103.761 11.796.147
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 73.743 -0,67 161,62 -80.812 11.918.639
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12.388 74.443 -14,27 161,02 -1.994.716 11.986.812
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12.044 86.831 -12,18 161,02 -1.939.325 13.981.528
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12.510 98.875 -11,23 161,02 -2.014.360 15.920.852
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12.519 111.385 -10,10 161,02 -2.015.809 17.935.213
2019-02-20 2019-02-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 241.695 241.695
2019-02-20 2019-02-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -241.695 272.777 -46,98
2019-02-14 2018-07-26 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 123.904 123.904
2019-02-14 2018-07-26 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -123.904 0 -100,00
2019-02-14 2018-07-13 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 121.035 123.904 4.218,72
2019-02-14 2018-07-13 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -121.035 514.472 -19,05
2018-06-22 2018-06-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9.000 9.000
2018-06-08 2018-06-06 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2018-03-09 2018-03-07 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 110.000 110.000
2018-03-08 2018-03-06 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -58.139 632.712 -8,42 172,00 -9.999.908 108.826.464
2017-06-08 2017-06-07 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14.000 14.000
2017-06-06 2017-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11.250 11.250
2017-02-17 2017-01-31 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 2.174 690.851 0,32 3,15 6.848 2.176.181
2017-02-10 2017-02-08 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 240.000 240.000 11,83 2.839.200 2.839.200
2016-06-24 2016-06-22 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 13.922 13.922 28,35 394.689 394.689
2016-06-07 2016-06-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11.250 11.250
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4.763.954 -0,02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4.763.954 -0,02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4.763.954 -0,02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -423 4.763.954 -0,01
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -423 678.569 -0,06
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 678.992 -0,12
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 678.992 -0,12
2016-02-02 2016-02-01 4 VYGR Voyager Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 200.000 200.000 11,09 2.218.000 2.218.000
2016-01-15 2016-01-14 4 VYGR Voyager Therapeutics, Inc.
Common Stock
P - Purchase 10.000 872.351 1,16 14,07 140.690 12.273.106
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
D - Sale to Issuer -624 0 -100,00
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
D - Sale to Issuer -374 0 -100,00
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -4.430 0 -100,00 92,78 -411.015
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -6.800 0 -100,00 74,77 -508.436
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
D - Sale to Issuer -10.000 0 -100,00 71,10 -711.000
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
D - Sale to Issuer -10.000 0 -100,00 69,14 -691.400
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10.000 0 -100,00 57,76 -577.600
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10.000 0 -100,00 44,58 -445.800
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10.000 0 -100,00 57,05 -570.500
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -20.000 0 -100,00 38,71 -774.200
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Common Stock
D - Sale to Issuer -478 0 -100,00 140,00 -66.920
2015-11-10 3 VYGR Voyager Therapeutics, Inc.
Common Stock
1.724.702
2015-11-10 3 VYGR Voyager Therapeutics, Inc.
Common Stock
1.724.702
2015-09-02 2015-09-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9.518 683.650 -1,37 52,10 -495.888 35.618.165
2015-09-02 2015-09-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -10.482 693.168 -1,49 52,69 -552.297 36.523.022
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -6.020 703.650 -0,85 66,42 -399.848 46.736.433
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9.158 709.670 -1,27 67,05 -614.044 47.583.374
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -4.822 718.828 -0,67 67,98 -327.800 48.865.927
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -803 723.650 -0,11 67,46 -54.170 48.817.429
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9.702 724.453 -1,32 68,12 -660.900 49.349.738
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1.859 734.155 -0,25 68,90 -128.085 50.583.280
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1.600 736.014 -0,22 70,50 -112.800 51.888.987
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -5.336 737.614 -0,72 71,47 -381.364 52.717.273
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 742.950 -0,09 72,44 -50.708 53.819.298
2015-06-15 2015-05-29 4 SIAL SIGMA ALDRICH CORP
Common Stock
G - Gift -7.779 478 -94,21
2015-06-03 2015-06-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11.250 11.250
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -8.705 743.650 -1,16 71,36 -621.153 53.063.815
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -3.291 752.355 -0,44 72,06 -237.162 54.217.560
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -4.604 755.646 -0,61 73,13 -336.710 55.263.641
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -3.400 760.250 -0,45 74,05 -251.774 56.297.425
2015-05-29 2015-05-28 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 13.922 13.922 73,13 1.018.116 1.018.116
2015-05-05 2015-05-01 4 BFAM Sage Therapeutics, Inc.
Common Stock
S - Sale X -20.000 763.650 -2,55 53,31 -1.066.200 40.710.182
2015-04-02 2015-04-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale -20.000 783.650 -2,49 48,51 -970.200 38.014.862
2015-01-28 2015-01-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 1.000 1.000 95,00 95.000 95.000
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -311 624 -33,26
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -373 374 -49,93
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 311 8.257 3,91
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 373 7.946 4,93
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
P - Purchase 10.000 803.650 1,26 18,00 180.000 14.465.700
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock
1.587.300
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock
1.587.300
2014-06-06 2014-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -373 747 -33,30
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
A - Award 935 935
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
A - Award 4.430 4.430
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 373 7.573 5,18
2014-01-03 2014-01-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 3.388 3.388
2013-06-10 2013-06-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2013-01-04 2013-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
A - Award 1.120 1.120
2013-01-04 2013-01-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
A - Award 6.800 6.800
2012-06-25 2012-06-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2012-05-04 2012-05-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10.000 10.000
2012-01-19 2012-01-03 4/A SIAL SIGMA ALDRICH CORP
Common Stock
A - Award 1.200 7.200 20,00
2012-01-05 2012-01-03 4 SIAL SIGMA ALDRICH CORP
Common Stock
A - Award 1.200 2.400 100,00
2011-06-13 2011-06-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2011-05-06 2011-05-04 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10.000 10.000 69,14 691.400 691.400
2011-01-05 2011-01-03 4 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1.200 6.000 25,00 67,30 80.760 403.800
2010-09-24 2010-09-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 30.000 30.000
2010-01-11 2010-01-07 4 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1.200 4.800 33,33 50,59 60.708 242.832
2009-05-07 2009-05-06 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10.000 10.000 44,58 445.780 445.780
2009-01-06 2009-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock, Par Value $1
A - Award 1.200 1.200
2009-01-06 2009-01-02 4/A SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1.200 3.600 50,00
2006-11-15 3 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)